IP Library Granted Patent US 10,736,942
Granted Patent B2
US 10,736,942 · App. 15/756,359 · Granted Aug 11, 2020

Formation of bone

Inventors: Fariba Dehghani (Sydney, AU); Ali Fathi (Sydney, AU); Suzanne Marie Mithieux (Sydney, AU); Anthony Steven Weiss (Sydney, AU)
Assignee: Allergan Pharmaceuticals International Limited
A61K38/39A61K9/0019A61K9/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,736,942
App. No.
15/756,359
Granted
Aug 11, 2020
Kind
B2
Abstract

Compositions and methods for inducing or promoting repair of a bone fracture.

Claims (16)

1. A method of inducing formation of bone in an individual consisting essentially of the steps of

providing an individual having a bone fracture or void requiring bone formation, and

providing a therapeutically effective amount of uncrosslinked tropoelastin to the individual to induce the formation of bone in the individual,

thereby inducing bone formation in the individual, wherein the tropoelastin is administered by injection.

2. The method of claim 1 , wherein the defect is a fracture and the individual is provided with the tropoelastin to promote the repair of the fracture.

3. The method of claim 2 , wherein the tropoelastin is administered directly to bone at the site of the fracture.

4. The method of claim 1 wherein the tropoelastin is administered directly to the bone callus.

5. The method of claim 4 wherein the tropoelastin is administered in the form of a gel, putty or paste.

6. The method of claim 5 wherein the tropoelastin is administered to a periosteal surface.

7. The method of claim 1 , wherein the defect is a void.

8. The method of claim 7 wherein the tropoelastin is administered directly to the bone at the site of the bone void.

9. The method of claim 8 wherein the tropoelastin is administered directly to the bone callus.

10. The method of claim 9 wherein the tropoelastin is administered by injection.

11. The method of claim 10 wherein the tropoelastin is administered in the form of a gel, putty or paste.

12. The method of claim 11 wherein the tropoelastin is administered to a periosteal surface.

13. The method of claim 1 , wherein the tropoelastin is a SHELδ26A, as shown in SEQ ID NO: 1.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: ELASTAGEN PTY LTD
To: ALLERGAN AUSTRALIA PTY LTD
Reel/Frame 048163/0642 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: ALLERGAN AUSTRALIA PTY LTD
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 048164/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2018
From: DEHGHANI, FARIBA; FATHI, ALI; MITHIEUX, SUZANNE MARIE; WEISS, ANTHONY STEVEN
To: ELASTAGEN PTY LTD
Reel/Frame 045938/0238 →